INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,000 | -23.5% | 34,423 | -20.5% | 0.00% | – |
| Q2 2023 | $17,000 | -51.4% | 43,307 | +0.5% | 0.00% | – |
| Q1 2023 | $35,000 | -31.4% | 43,089 | +27.0% | 0.00% | – |
| Q4 2022 | $51,000 | -15.0% | 33,915 | -3.9% | 0.00% | – |
| Q3 2022 | $60,000 | 0.0% | 35,274 | +0.0% | 0.00% | – |
| Q2 2022 | $60,000 | -52.8% | 35,273 | -1.7% | 0.00% | – |
| Q1 2022 | $127,000 | -29.4% | 35,873 | -2.7% | 0.00% | – |
| Q4 2021 | $180,000 | -32.1% | 36,854 | -0.0% | 0.00% | -100.0% |
| Q3 2021 | $265,000 | -20.9% | 36,870 | +2.3% | 0.00% | 0.0% |
| Q2 2021 | $335,000 | +1.2% | 36,050 | +1.1% | 0.00% | 0.0% |
| Q1 2021 | $331,000 | +6.8% | 35,668 | +1.5% | 0.00% | 0.0% |
| Q4 2020 | $310,000 | -22.7% | 35,148 | +1.9% | 0.00% | -50.0% |
| Q3 2020 | $401,000 | -68.6% | 34,500 | -27.4% | 0.00% | -71.4% |
| Q2 2020 | $1,278,000 | +305.7% | 47,510 | +12.0% | 0.01% | +250.0% |
| Q1 2020 | $315,000 | +86.4% | 42,408 | -18.1% | 0.00% | +100.0% |
| Q4 2019 | $169,000 | -8.6% | 51,758 | -44.2% | 0.00% | 0.0% |
| Q3 2019 | $185,000 | -33.7% | 92,708 | -0.7% | 0.00% | -50.0% |
| Q2 2019 | $279,000 | -20.1% | 93,318 | +0.2% | 0.00% | 0.0% |
| Q1 2019 | $349,000 | -5.9% | 93,154 | +0.7% | 0.00% | -33.3% |
| Q4 2018 | $371,000 | -36.9% | 92,504 | -12.3% | 0.00% | -25.0% |
| Q3 2018 | $588,000 | +53.5% | 105,504 | +9.6% | 0.00% | +33.3% |
| Q2 2018 | $383,000 | -16.0% | 96,279 | +0.1% | 0.00% | -25.0% |
| Q1 2018 | $456,000 | +12.3% | 96,204 | -1.8% | 0.00% | +33.3% |
| Q4 2017 | $406,000 | -24.5% | 97,929 | +14.2% | 0.00% | -40.0% |
| Q3 2017 | $538,000 | +75.2% | 85,753 | +119.1% | 0.01% | +66.7% |
| Q2 2017 | $307,000 | +204.0% | 39,140 | +150.3% | 0.00% | +200.0% |
| Q1 2017 | $101,000 | -1.9% | 15,640 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $103,000 | -12.7% | 15,640 | +43.3% | 0.00% | -50.0% |
| Q2 2014 | $118,000 | – | 10,913 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |